Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes.

A combination method of using microneedle pretreatment and elastic liposomes was developed to increase skin permeation of drugs with high molecular weight and poor water solubility. Docetaxel (DTX, MW=807.9) was chosen as a model drug. DTX liposomal systems with and without elastic properties were prepared and characterized. The effect of the developed formulations on the permeation of DTX across both rat and porcine skin was investigated in vitro. The combination effect of microneedle pretreatment and elastic liposomes on the permeability of DTX was evaluated using porcine skin in vitro. The following results were obtained: (1) Elastic liposomes loaded with DTX can enhance transdermal delivery of DTX without microneedle treatment. (2) An enhanced transdermal flux (1.3-1.4 microg/cm(2)/h) for DTX from all liposomal formulations was observed after microneedle treatment. Importantly, the lag time obtained following the application of elastic liposomes through microneedle-treated skin was decreased by nearly 70% compared with that obtained from conventional liposomes. These results suggest that the combination of elastic liposomes with microneedle pretreatment can be a useful method to increase skin permeation of drugs with high molecular weight and poor water solubility.

[1]  Mark G. Allen,et al.  Lack of pain associated with microfabricated microneedles. , 2001 .

[2]  P. Ramarao,et al.  In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species. , 2001, Journal of Controlled Release.

[3]  A. Schätzlein,et al.  Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo , 1997 .

[4]  J. Hadgraft,et al.  Influence of phloretin and 6-ketocholestanol on the skin permeation of sodium-fluorescein. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Qiaojun He,et al.  Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid. , 2007, Bioorganic & medicinal chemistry.

[6]  N. K. Jain,et al.  Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. , 2007, Journal of pharmaceutical sciences.

[7]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[8]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[9]  G. E. El Maghraby,et al.  Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.

[10]  D. Barrow,et al.  Microfabricated silicon microneedles for nonviral cutaneous gene delivery , 2004, The British journal of dermatology.

[11]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[12]  E. Touitou,et al.  Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.

[13]  N. K. Jain,et al.  Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization, and performance evaluation , 2005, AAPS PharmSciTech.

[14]  M. Mezei,et al.  Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.

[15]  B. Godin,et al.  Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Adrian C. Williams,et al.  Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes , 2001, The Journal of pharmacy and pharmacology.

[17]  M. Foldvari,et al.  Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. , 1990, Journal of microencapsulation.

[18]  M. Mezei,et al.  Topical Anesthesia of the Skin by Liposome‐Encapsulated Tetracaine , 1988, Anesthesia and analgesia.

[19]  O. Abdallah,et al.  Lipid vesicles for skin delivery of drugs: reviewing three decades of research. , 2007, International journal of pharmaceutics.

[20]  J. Bouwstra,et al.  Vesicles as a tool for transdermal and dermal delivery. , 2005, Drug discovery today. Technologies.

[21]  P. Agache,et al.  Effect of occlusion on in vitro percutaneous absorption of two compounds with different physicochemical properties. , 1992, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[22]  K. Sugibayashi,et al.  Species differences in percutaneous absorption of nicorandil. , 1991, Journal of pharmaceutical sciences.

[23]  M. Mezei,et al.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.

[24]  R. Marks,et al.  The occlusive effects of protective gloves on the barrier properties of the stratum corneum. , 1993, Current problems in dermatology.

[25]  Wijaya Martanto,et al.  Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.

[26]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[27]  K. Sugibayashi,et al.  Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran. , 2006, International journal of pharmaceutics.

[28]  F. Dosio,et al.  Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[29]  C. van Nostrum,et al.  The effect of core composition in biodegradable oligomeric micelles as taxane formulations. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  A. Billich,et al.  Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. , 2001, International journal of pharmaceutics.

[31]  Regina Luttge,et al.  Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .

[32]  Amit Jain,et al.  Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel. , 2004, Journal of pharmaceutical sciences.

[33]  Diane E. Sutter,et al.  Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.

[34]  Dorian Liepmann,et al.  Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[35]  R. Guy,et al.  Bioavailability of topically administered steroids: a "mass balance" technique. , 1988, The Journal of investigative dermatology.

[36]  M. Riley,et al.  Comparative topical anaesthesia of EMLA and liposome-encapsulated tetracaine , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[37]  M. Foldvari In Vitro Cutaneous and Percutaneous Delivery and in Vivo Efficacy of Tetracaine from Liposomal and Conventional Vehicles , 1994, Pharmaceutical Research.

[38]  J. Schellens,et al.  Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes , 2001, Investigational New Drugs.

[39]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[40]  T M Morgan,et al.  Transdermal penetration enhancers: applications, limitations, and potential. , 1999, Journal of pharmaceutical sciences.

[41]  Mark G. Allen,et al.  Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.

[42]  Mark G. Allen,et al.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.